Neil E. Stahl - 09 Dec 2022 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
EVP Research and Development
Signature
/s/**Neil Stahl
Issuer symbol
REGN
Transactions as of
09 Dec 2022
Net transactions value
-$351,028
Form type
4
Filing time
13 Dec 2022, 15:11:18 UTC
Previous filing
08 Aug 2022
Next filing
20 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Gift $0 -330 -0.63% $0.000000 52,465 08 Nov 2022 Direct
transaction REGN Common Stock Tax liability $351,028 -466 -0.89% $753.28 51,999 09 Dec 2022 Direct
holding REGN Common Stock 5,814 09 Dec 2022 By 401(k) Plan
holding REGN Common Stock 4,605 09 Dec 2022 by Spouse as Trustee
* An asterisk sign (*) next to the price indicates that the price is likely invalid.